Cell Instructive Materials For Engineering Vascular Grafts
Cell Instructive Materials For Engineering Vascular Grafts
批准号:
8683218
负责人:
Robert E Akins
金额:
$35.23万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-17 至 2017-05-31
关键词:
AnatomyAngioplastyAnimal ModelArteriesAttenuatedAutologousBiocompatible MaterialsBiologicalBlood CirculationBlood VesselsBypassCadherinsCardiovascular Surgical ProceduresCardiovascular systemCathetersCause of DeathCell ProliferationCell physiologyCellsCharacteristicsClinicalCongenital AbnormalityCoronaryCoronary Artery BypassCoronary heart diseaseDataDialysis procedureDrug FormulationsEncapsulatedEngineeringFGF2 geneFailureFibroblast Growth FactorFibroblastsFibrosisGelGene ExpressionGoalsGrowthGrowth FactorHarvestHealedHeparinHydrogelsHyperplasiaImplantIn SituInjectableInjuryInterventionMechanicsMedialMediator of activation proteinMetabolicMolecular ProfilingMorbidity - disease rateMyofibroblastOperative Surgical ProceduresOutcomePathogenesisPericytesPeripheralPeripheral arterial diseasePhenotypeProceduresPropertyPsyche structureRiskSeriesSignal TransductionSignaling MoleculeStenosisStressStructureSurfaceTGFBR1 geneTarsTimeTissuesTransplantationVascular DiseasesVascular GraftVascularizationVeinsVenousWorkbasecell behaviorcell growthhealinghemodynamicsimprovedin vivomalformationmeetingsmolecular phenotypemortalitynotch proteinpublic health relevancerepairedresearch studyresponserhoscaffoldvasa vasorum
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Coronary and peripheral arterial diseases are leading causes of morbidity and mortality in the US and worldwide. Principal treatments include bypass graft surgery and catheter-based procedures to open blockages (angioplasty). Angioplasty and cardiovascular surgery are also widely employed to maintain venous access for dialysis and to repair congenital cardiovascular malformations. In all cases, stenosis, fibrosis, and vessel failur are significant post-procedure problems with nearly 50% of autologous vein grafts used in peripheral or coronary artery bypass surgery failing over time due to maladaptive vessel remodeling. Vessel failures are driven to a large extent by cellular responses elicited by tissue injury during manipulation and by altered hemodynamic stresses after the re-establishment of circulation. Of principal concern, maladaptive cascades initiated by adventitial fibroblasts (AFs) residing in the exterior portion of at-risk vessels are now widely recognized as major contributors to pathogenesis in grafted and manipulated vessels. Instructive biomaterials that attenuate maladaptive cellular responses of AFs, encourage adaptation to altered hemodynamic conditions, and provide cellular material for populating a healthy neo-adventitium and vaso vasorum would have significant clinical impact resulting in decreased procedure failure rates and a potential increase in the ability to use pre-treated autologous vessels for transplantation. We thus seek to develop injectable, PEG-based polymeric biomaterials that can be placed along the exterior of at-risk vessels either prior to or just after manipulation, as a facile clinial intervention to beneficially influence AF responses and vessel remodeling. Based on extensive preliminary data indicating our ability to guide AF phenotypes with materials strategies, our three aims are to (i) determine in detail the effects of hydrogel mechanical properties on adventitial cell phenotype, (ii) evaluate the effects of critical cell signaling molecules co-delivered to cells by hydrogels, and (iii) assess the effects of hydrogels placed on target vessels
in an animal model. Improving our understanding of the central mechanisms that drive adventitial cell phenotype will afford instructive materials that can reduce stenosis, attenuate fibrosis, and encourage formation of healthy vasa vasorum to improve outcomes after vascular procedures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Subproject Title: Clinical Research Education, Mentoring and Career Development Core
-
批准号:9312847
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2017
-
负责人:Robert E Akins
-
依托单位:
The DE Nemours/duPont Hospital for Children IDeA States Pediatric Clinical Trials Network Site
-
批准号:10475075
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2016
-
负责人:Robert E Akins
-
依托单位:
Clinical Research Education, Mentoring and Career Development Core
-
批准号:9085311
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2016
-
负责人:Robert E Akins
-
依托单位:
Clinical Research Education, Mentoring and Career Development Core
-
批准号:8856605
-
项目类别:
-
资助金额:$40.11万
-
财政年份:2015
-
负责人:Robert E Akins
-
依托单位:
Clinical Research Education, Mentoring and Career Development Core
-
批准号:8741975
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2014
-
负责人:Robert E Akins
-
依托单位:
Clinical Research Education, Mentoring and Career Development Core
-
批准号:8608777
-
项目类别:
-
资助金额:$42.69万
-
财政年份:2013
-
负责人:Robert E Akins
-
依托单位:
Cell Instructive Materials For Engineering Vascular Grafts
-
批准号:8439601
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2013
-
负责人:Robert E Akins
-
依托单位:
BIOMATERIALS FOR CARDIOVASCULAR TISSUE ENGINEERING
-
批准号:8359621
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2011
-
负责人:Robert E Akins
-
依托单位:
Development of neuromuscular junctions in children with cerebral palsy
-
批准号:7425945
-
项目类别:
-
资助金额:$6.25万
-
财政年份:2007
-
负责人:Robert E Akins
-
依托单位:
Development of neuromuscular junctions in children with cerebral palsy
-
批准号:7257361
-
项目类别:
-
资助金额:$6.38万
-
财政年份:2007
-
负责人:Robert E Akins
-
依托单位:
海外基金